Sauerwein W - Search Results

1

Jardel P, Sauerwein W, Olivier T, Bensoussan E, Maschi C, Lanza F, Mosci C, Gastaud L, Angellier G, Marcy PY, Herault J, Caujolle JP, Dendale R, Thariat J. Jardel P, et al. Among authors: sauerwein w. Cancer Treat Rev. 2014 Dec;40(10):1119-28. doi: 10.1016/j.ctrv.2014.09.006. Epub 2014 Oct 5. Cancer Treat Rev. 2014. PMID: 25451606 Review.

2

Quantification of dose perturbations induced by external and internal accessories in ocular proton therapy and evaluation of their dosimetric impact.

Carnicer A, Angellier G, Thariat J, Sauerwein W, Caujolle JP, Hérault J. Carnicer A, et al. Among authors: sauerwein w. Med Phys. 2013 Jun;40(6):061708. doi: 10.1118/1.4807090. Med Phys. 2013. PMID: 23718587

3

[Malignant tumours of the eye: Epidemiology, diagnostic methods and radiotherapy].

Jardel P, Caujolle JP, Gastaud L, Maschi C, Sauerwein W, Thariat J. Jardel P, et al. Among authors: sauerwein w. Cancer Radiother. 2015 Dec;19(8):762-74. doi: 10.1016/j.canrad.2015.04.008. Epub 2015 Oct 21. Cancer Radiother. 2015. PMID: 26508321 French.

4

[Operative therapy and irradiation of conjunctival melanoma].

Westekemper H, Meller D, Darawsha R, Scholz SL, Flühs D, Steuhl KP, Hérault J, Thariat J, Sauerwein W. Westekemper H, et al. Among authors: sauerwein w. Ophthalmologe. 2015 Nov;112(11):899-900, 902-6. doi: 10.1007/s00347-015-0147-y. Ophthalmologe. 2015. PMID: 26475337 Review. German.

5

Ocular proton therapy, pencil beam scanning high energy proton therapy or stereotactic radiotherapy for uveal melanoma; an in silico study.

Gerard A, Peyrichon ML, Vidal M, Barnel C, Sauerwein W, Carnicer A, Angellier G, Mathis TM, Mishra KK, Thariat J, Herault J. Gerard A, et al. Among authors: sauerwein w. Cancer Radiother. 2022 Nov;26(8):1027-1033. doi: 10.1016/j.canrad.2022.03.003. Epub 2022 Jul 5. Cancer Radiother. 2022. PMID: 35803862

6

Study of the secondary neutral radiation in proton therapy: toward an indirect in vivo dosimetry.

Carnicer A, Letellier V, Rucka G, Angellier G, Sauerwein W, Herault J. Carnicer A, et al. Among authors: sauerwein w. Med Phys. 2012 Dec;39(12):7303-16. doi: 10.1118/1.4765049. Med Phys. 2012. PMID: 23231280

7

An indirect in vivo dosimetry system for ocular proton therapy.

Carnicer A, Letellier V, Rucka G, Angellier G, Sauerwein W, Hérault J. Carnicer A, et al. Among authors: sauerwein w. Radiat Prot Dosimetry. 2014 Oct;161(1-4):373-6. doi: 10.1093/rpd/nct284. Epub 2013 Nov 11. Radiat Prot Dosimetry. 2014. PMID: 24222711

8

30 years of ocular proton therapy, the Nice view.

Hérault J, Gérard A, Carnicer A, Aloi D, Peyrichon ML, Barnel C, Vidal M, Angellier G, Fayaud D, Grini JC, Giusto A, Armando C, Donadey G, Cabannes M, Dumas S, Payan Y, Di Carlo JF, Salicis C, Bergerot JM, Rolion M, Trimaud R, Hofverberg P, Mandrillon P, Sauerwein W, Thariat J. Hérault J, et al. Among authors: sauerwein w. Cancer Radiother. 2022 Nov;26(8):1016-1026. doi: 10.1016/j.canrad.2022.03.004. Epub 2022 Jul 5. Cancer Radiother. 2022. PMID: 35803860

9

Clinical and technical requirements for proton treatment planning of ocular diseases. The SERAG (South Europe Radiotherapy Group).

Chauvel P, Sauerwein W, Bornfeld N, Friedrichs W, Brassart N, Courdi A, Hérault J, Pignol JP, Bondiau PY, Malandain G. Chauvel P, et al. Among authors: sauerwein w. Front Radiat Ther Oncol. 1997;30:133-42. Front Radiat Ther Oncol. 1997. PMID: 9205893 No abstract available.

10

Long-term results after low dose ocular irradiation for choroidal haemangiomas.

Schilling H, Sauerwein W, Lommatzsch A, Friedrichs W, Brylak S, Bornfeld N, Wessing A. Schilling H, et al. Among authors: sauerwein w. Br J Ophthalmol. 1997 Apr;81(4):267-73. doi: 10.1136/bjo.81.4.267. Br J Ophthalmol. 1997. PMID: 9215052 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page